New Launch17 Oct 2025, 08:41 pm
Novelix Pharmaceuticals Ltd Enters Agreement with GMBU e.V. for Technology Transfer of Astaxanthin Production
AI Summary
Novelix Pharmaceuticals Ltd, formerly known as Trimurthi Limited, has entered into an agreement with GMBU e.V., Halle (Saale), Germany for Technology Transfer for the production and scale up of Astaxanthin at the company’s research facilities in Hyderabad, India. This agreement was executed on 17th October, 2025 and does not involve any related party transactions. No special rights have been agreed upon between the parties, and no shares will be issued to them. This development is expected to enhance Novelix Pharmaceuticals Ltd's capabilities in the pharmaceutical sector.
Key Highlights
- Novelix Pharmaceuticals Ltd has entered into a technology transfer agreement with GMBU e.V., Halle (Saale), Germany.
- The agreement is for the production and scale up of Astaxanthin at the company’s research facilities in Hyderabad, India.
- No related party transactions are involved in this agreement.
- No special rights have been agreed upon between the parties.
- This development is expected to enhance Novelix Pharmaceuticals Ltd's capabilities in the pharmaceutical sector.